Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events

OBJECTIVE: Distinguishing immune-related adverse events (irAEs) caused by immune checkpoint inhibitors (ICIs) from the AEs caused by chemotherapy, targeted therapy, or infection is highly difficult. This study offers new insights into evaluating the diagnosis, differential diagnostic, and prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Weihong, Meng, Yuan, Yang, Lin, Shen, Meng, Zhou, Li, Li, Runmei, Wang, Yang, Du, Weijiao, Xiong, Yanjuan, Han, Ying, Zhang, Xinwei, Liu, Liang, Ren, Xiubao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610162/
https://www.ncbi.nlm.nih.gov/pubmed/34378879
http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610162/
https://www.ncbi.nlm.nih.gov/pubmed/34378879
http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0037

Ejemplares similares